First Read | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

41,058 results for “First Read”

Trials

View all 19979 →

Community Enabled Readiness for First 1000 Days Learning Ecosystem

750 participants · First posted Feb 19, 2020

Improving the Academic Performance of First-Grade Students With Reading and Math Difficulty

385 participants · First posted Jun 19, 2019

The Effect of Peer Support on The Clinical Readiness of First Year Nursing Students

103 participants · First posted Sep 30, 2025

Drugs

View all 297 →

first-generation polyamine analogs (SLIL)

first generation anti-inflammatory compounds

CAR-T (Tianjin First Center Hospital)

Organizations

View all 246 →

Peking University First Hospital (Peking Univesity First Medical School)

China

Nanjing First Hospital

China

FIRST PRIORITY INCORPORATED

United States

News

View all 20536 →

Aidoc Receives FDA Breakthrough Device Designation for AI That Drafts Radiology Reports

New Zealand Introduces Fast-Track Approval Amendments to Accelerate Supermarket Development and Reduce Healthcare Access Barriers

Relief Therapeutics' RLF-OD032 Achieves Bioequivalence to KUVAN in Pivotal PKU Study

Page 1 of 4106